Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure. In this multinational, open-label, randomised, parallel-group trial (STRONG-HF), patients aged 18–85 years admitted to hospital with acute hea...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Lancet (British edition) Ročník 400; číslo 10367; s. 1938 - 1952
Hlavní autoři:	Mebazaa, Alexandre, Davison, Beth, Chioncel, Ovidiu, Cohen-Solal, Alain, Diaz, Rafael, Filippatos, Gerasimos, Metra, Marco, Ponikowski, Piotr, Sliwa, Karen, Voors, Adriaan A, Edwards, Christopher, Novosadova, Maria, Takagi, Koji, Damasceno, Albertino, Saidu, Hadiza, Gayat, Etienne, Pang, Peter S, Celutkiene, Jelena, Cotter, Gad
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Ltd 03.12.2022 Elsevier Limited Elsevier
Témata:	Adverse events Angiotensin Blood pressure Brain natriuretic peptide Cardiology Cardiology and cardiovascular system Congestive heart failure Death Effectiveness Enzymes Female Health services Heart Failure Hospitals Human health and pathology Humans Laboratories Life Sciences Male Middle Aged Mineralocorticoid Receptor Antagonists - therapeutic use Minority & ethnic groups Missing data Mortality Patients Peptides Potassium Quality of Life Renin Risk Risk reduction Safety Stroke Volume Titration Treatment Outcome Ventricle Ventricular Function, Left
ISSN:	0140-6736, 1474-547X, 1474-547X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!